Table 3 The calculated and experimental changes in binding free energies of 8 sNRIs-hNET complexes (2 sNRIs against 4 single-point mutations) before and after those mutations in hNET25 (ΔG is in kcal/mol).

From: Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study

sNRIs studied

Single point mutations in hNET

Calculated value

Experimental value25

ΔΔGcalca

Fold-change of potency b

Fold-change of potency c

ΔΔGexpd

Atomoxetine

F72Y

−0.03

0.95

0.78 (0.55~1.14)

−0.15 (−0.35~0.08)

N153S

−0.31

0.59

2.33 (1.73~3.29)

0.50 (0.33~0.71)

F323Y

1.93

25.95

3.89 (2.45~6.14)

0.81 (0.53~1.08)

S419T

1.27

8.52

12.67 (8.73~18.86)

1.51 (1.28~1.74)

Maprotiline

F72Y

−0.31

0.59

0.59 (0.34~0.99)

−0.31 (−0.64~−0.01)

N153S

0.05

1.09

2.34 (1.44~3.75)

0.50 (0.22~0.78)

F323Y

0.96

5.05

4.97 (3.21~7,75)

0.95 (0.69~1.21)

S419T

1.36

9.92

5.88 (3.61~9.43)

1.05 (0.76~1.33)

  1. Detail information of each energy term can be found in SI, Table S4.
  2. aΔΔGcalc = Gmutation − ΔGwild type.
  3. bFold-changes of potency were derived from ΔΔGcalc by the equation ΔΔGcalc = RTln (FCpotency).
  4. cFold-changes of potency measured by Ki values 25. Numbers out of the bracket indicated the fold-changes derived from the medium experimental values of both and . The first number in the bracket indicated the minimum fold-changes, while the second one indicated the maximum fold-changes.
  5. dΔΔGexp were derived from the FCpotency by the equation ΔΔGexp = RTln (FCpontency).